President Donald Trump has signed an executive order that he claims will cut prescription drug prices supplied to the US to ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use ...

Tom Keith-Roach, president of AZ's UK business, said: "The UK approval of Trixeo Aerosphere with the [new] propellant marks a ...

"We can use…AI to estimate a person's biological age from face pictures, and our study shows that information can be ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

President Donald Trump is rumoured to be resurrecting a policy proposed in his first term that would see drug prices offered to federal programmes tied to those offered overseas. According to ...

As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of pharma. Join editor-in ...

To add to the relevance of this point, not only are HCPs expecting them, but we know that they work. In fact, as IQVIA’s ChannelDynamics shows, the impact of remote detailing on HCPs reported ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

The industry is showing its teeth, as companies have started slashing positions. Ben Hargreaves reviews how the job losses that started earlier in the biotech industry have quickly spread to all ...